Azalea Therapeutics
San Francisco, US · Founded 2023 · 36 employees on LinkedIn · 4 known investors
Find your way into Azalea Therapeutics
495 people in our graph share verified history with the Azalea Therapeutics team — schools, employers, funds. One of them is your warm intro.
Ken Chenaultunlockedknows Connor Tsuchida · together at NYU Langone Medical Center (overlapped)
×3knows the team · via University of California, Berkeley
×2knows the team · via University of Washington
knows the team · via University of California, San Francisco
knows the team · via Azalea Therapeutics
knows the team · via NYU Langone Medical Center
Azalea Therapeutics develops precision genome editing therapies that engineer T cells directly inside the patient's body to create cancer immunotherapies, using proprietary delivery vehicles to target and modify specific genetic loci without ex vivo cell manipulation.
Founders & leadership
Azalea Therapeutics was founded in 2023 by Jennifer Doudna, Rodolphe Barrangou, Krishnendu Roy, and Connor Tsuchida.
JD
Jennifer DoudnaCo-founder, Nobel Laureate in Chemistry and Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences, UC Berkeley
RB
Rodolphe BarrangouCo-founder, Associate Professor of Medicine, UCSF
KR
Krishnendu RoyCo-founder, Professor of Bioengineering, Stanford University
CT
Connor TsuchidainScientific Co-FounderConnor Tsuchida is a bioengineer who earned his PhD under Jennifer Doudna at UC Berkeley and UCSF, with prior training at the University of Washington, Pfizer, Harvard University, and NYU School of Medicine. He is scientific cofounder of Azalea Therapeutics, which develops in vivo genome editing therapies for cancer immunotherapy.30 Under 30 2024
Investors · 4
Competitors · 1
by search overlap
Companies competing with Azalea Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Biopharma Startup Funding (2026) – New Market Pitchnewmarketpitch.com · Jul 2026Frequently asked questions
- What does Azalea Therapeutics do?
- Azalea Therapeutics develops precision genome editing therapies that engineer T cells directly inside the patient's body to create cancer immunotherapies, using proprietary delivery vehicles to target and modify specific genetic loci without ex vivo cell manipulation.
- Who founded Azalea Therapeutics?
- Azalea Therapeutics was founded by Jennifer Doudna, Rodolphe Barrangou, Krishnendu Roy, Connor Tsuchida in 2023.
- Who are Azalea Therapeutics's investors?
- Azalea Therapeutics's investors include Third Rock Ventures, RA Capital, Sozo Ventures, Yosemite.
- Where is Azalea Therapeutics headquartered?
- Azalea Therapeutics is headquartered in San Francisco, US.